Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced aseptic meningitis.

Eustachio Nettis1, Gianfranco Calogiuri, Maria Cristina Colanardi

  • 1Department of Medical Clinic, Immunology and Infectious Diseases, Division of Allergy and Clinical Immunology, University of Bari, Italy. e.nettis@allergy.uniba.it

Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|May 29, 2003
PubMed
Summary

Drug-induced aseptic meningitis (DIAM) is a rare complication of certain medications, presenting with distinct symptoms like fever and headache. While the exact cause is unknown, DIAM typically resolves without long-term effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

Dermatology and therapy·2026
Same author

Evaluation of Outcomes of Dupilumab Therapy in Patients with Atopic Dermatitis - A Single-Center Retrospective Longitudinal Study.

Indian journal of dermatology·2026
Same author

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.

Biomedicines·2026
Same author

Long-Term Effectiveness of Dupilumab in Eosinophilic Esophagitis: Results From the DUPEOETALY Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patients.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper.

Allergy·2026

Area of Science:

  • Neurology
  • Pharmacology
  • Immunology

Background:

  • Aseptic meningitis is an infrequent but recognized adverse effect of various drug therapies.
  • Drug-induced aseptic meningitis (DIAM) presents with a characteristic set of symptoms including fever, neck stiffness, headache, confusion, nausea, and vomiting.

Purpose of the Study:

  • To review the clinical presentation, causative agents, diagnostic challenges, and outcomes of drug-induced aseptic meningitis.
  • To highlight the importance of considering DIAM in differential diagnoses and the potential role of immunological mechanisms.

Main Methods:

  • Review of literature on drug-induced aseptic meningitis.
  • Analysis of clinical presentations and implicated drug categories (NSAIDs, antimicrobials, IVIg, monoclonal antibodies, vaccines).

Related Experiment Videos

  • Discussion of diagnostic approaches, including exclusion of infectious causes and supervised rechallenge.

    • Main Results:

    • Commonly implicated drugs often trigger DIAM through immunological pathways, though the precise pathogenesis remains unclear.
    • Diagnosis is challenging, requiring exclusion of infectious meningitis and potentially confirmed by medically supervised rechallenge.
    • The prognosis for DIAM is generally favorable, with most patients experiencing a full recovery without lasting sequelae.

    Conclusions:

    • Drug-induced aseptic meningitis is a distinct clinical entity with a generally good prognosis.
    • Awareness of causative agents and diagnostic criteria is crucial for timely management.
    • Further research into the pathogenetic mechanisms of DIAM is warranted.